Loading…
Login
Scholar Register
Business Register
Subscribe
Loading…
Article Title
Abstract
Keyword
Category
MESH Heading
Grant Agency
RCAID
DOI
PMID
PMCID
Author
Affiliation
Email
Journal Title
ISSN
Publisher
Loading…
Contains
Equals
Find an Article
Find an Article (55707912)
Find a Category (125)
Find a Journal (6164)
Find a Scholar (4374)
Find an Academic Assistant (18)
Find an Article PDF (4640408)
Today's Articles (207)
Subscriber (50363)
Citation(s) in
RCA
1
(from Reference Citation Analysis)
Indexed Articles
Today (0)
Yesterday (0)
This Week (0)
Last Week (0)
Current Month (0)
Last Month (0)
Ranked By
Impact Index Per Article
Citation(s) in
RCA
Results Analysis
Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis
Results Analysis
Year Published
2008 (1)
Show more
Refine
Article Statistics
Open (1)
PubMed (1)
RCA (1)
SCIE (1)
Refine
Publication Titles
PLOS MEDICINE (1)
Show more
Refine
Category
Medicine, General & Internal (1)
Show more
Refine
For:
Ellis MJ
, Crowder R.
“PIKing” the Winner for Phosphatidylinositol 3-Kinase Inhibitors in ErbB2-Positive Breast Cancer: Let's Not “PTENed” It's Easy!
Clin Cancer Res
2007;
13
:5661-2. [PMID:
17908952
DOI:
10.1158/1078-0432.ccr-07-1698
]
[
Citation(s) in
RCA
: 1
]
[
Impact Index Per Article: 0.1
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 11/16/2022]
Number
Cited by Other Article(s)
1
Weil RJ
. Incorporating molecular tools into early-stage clinical trials.
PLoS Med
2008;
5
:e21. [PMID:
18215108
PMCID:
PMC2211557
DOI:
10.1371/journal.pmed.0050021
]
[
Citation(s) in
RCA
: 6
]
[
Impact Index Per Article: 0.4
]
[
Reference Citation Analysis
]
[
Abstract
]
[
MESH Headings
]
[
Track Full Text
]
[
Figures
]
[
Journal Information
]
[
Submit a Manuscript
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 11/18/2022]
Open
Abstract
The author discusses the implications of a new phase I trial investigating the role of rapamycin in patients with glioblastoma.
Collapse
Key Words
Collapse
MESH Headings
Animals
Antineoplastic Agents/therapeutic use
Brain Neoplasms/drug therapy
Brain Neoplasms/enzymology
Brain Neoplasms/genetics
Brain Neoplasms/surgery
Clinical Trials as Topic/methods
Combined Modality Therapy
Drug Delivery Systems
Drug Evaluation, Preclinical
ErbB Receptors/antagonists & inhibitors
Glioblastoma/drug therapy
Glioblastoma/enzymology
Glioblastoma/genetics
Glioblastoma/surgery
Humans
Neoplasm Proteins/antagonists & inhibitors
Neoplasm Recurrence, Local/drug therapy
Neoplasm Recurrence, Local/surgery
PTEN Phosphohydrolase/deficiency
PTEN Phosphohydrolase/physiology
Protein Kinase Inhibitors/therapeutic use
Protein Kinases/physiology
Protein-Tyrosine Kinases/antagonists & inhibitors
Proto-Oncogene Proteins c-akt/physiology
Signal Transduction/drug effects
Sirolimus/therapeutic use
TOR Serine-Threonine Kinases
Collapse
Grants
Collapse
Affiliation(s)
Robert J Weil
Brain Tumor and Neuro-Oncology Center, Department of Neurosurgery and the Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
Collapse
Page 1 of 1
1
Loading…
Loading…
Export Articles to File
Export Citation Analysis
Export Citation Analysis
Article Number From
to
A maximum of 600 records can be exported at a time.
Format:
*
Excel
Plain Text
PDF
WORD
Invalid value
Loading…
Click to Download the Exported File
Loading…
Loading…
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Select the Category
Loading…
Loading…
Impact Index Per Article
Calculation for Impact Index Per Article
Times Cited ÷ Number of Years = Impact Index Per Article
TM
Loading…